DPP4 in Diabetic Nephropathy Research suggests that DPP4 may play a role in the receptor axis for advanced glycation end products (RAGE), which is crucial for the development of diabetic nephropathy
To date the studies with NAC have progressed the most toward therapeutic potential
Clinically, integration is most compelling when standard work-up is non-diagnostic or repeated failures suggest heterogeneity beyond embryo morphology-especially euploid recurrent implantation failure (RIF) and recurrent pregnancy loss (RPL
For ALCAR and L-carnitine, measurements for once daily regimens did not differ from the twice daily regimen
Controversially, emerging evidence suggest that metformin has potential clinical applications in stem cell medicine, regenerative medicine and anti-aging (Jiang and Liu, 2020)
Classification of variants (e.g., font color) as per Table 4 and Methods